Phillip Foreman

Phillip Foreman

Health Technology
Health Services
Process Industries

Profile

Phillip Foreman has been a Director of TheraBiogen, Inc. since August 31, 2008.
Dr. Forman was appointed as Medical Director of the New York Hyperbaric in 2001.
From July 2005 to January 18, 2007, he served as Chief Executive Officer of American Hyperbaric, Inc. Previously, Dr. Forman was a Principal at Merck & Co., Inc., Pharmacia, OrthoBiotech, Novartis/Organogenesis, Johnson & Johnson, Monsanto, Ortho-McNiel, Alpha Therapeutics, and Ortec International.
He was a Principal at Staten Island University Hospital and Associate and a Director of Residency Program for Staten Island University Hospital.
Dr. Forman has extensive experience in wound care.
He received a degree from the American Board of Podiatric Surgery and a PhD in Podiatric Medicine from the Pennsylvania College of Podiatric Medicine.

Former positions of Phillip Foreman

CompaniesPositionEnd
Director/Board Member 2010-01-06
American Hyperbaric, Inc. President 2007-01-17
Corporate Officer/Principal -
Corporate Officer/Principal -
Alpha Therapeutics Corp. Corporate Officer/Principal -
See the detail of Phillip Foreman's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Phillip Foreman's experience

Connections

7

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies11

Health Technology

New York Hyperbaric

American Hyperbaric, Inc.

Health Services

Health Technology

Process Industries

Health Technology

Consumer Non-Durables

Process Industries

Alpha Therapeutics Corp.

Health Technology

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Phillip Foreman